Rivista
/
/
SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
JoVE Journal
Biologia
È necessario avere un abbonamento a JoVE per visualizzare questo.  Accedi o inizia la tua prova gratuita.
JoVE Journal Biologia
SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
DOI:

07:39 min

June 28, 2019

, , , , ,

Capitoli

  • 00:04Titolo
  • 01:06Generation of Senescent Murine Embryonic Fibroblast (MEF) 12-15 Days
  • 03:46Senescent Associated -Galactosidase (SA–Gal) Screening Assay 2-3 Days
  • 06:06Results: Identification of Senotherapeutics by Measuring SA–Gal Activity in Single Cells
  • 06:48Conclusion

Summary

Traduzione automatica

Cellular senescence is the key factor in the development of chronic age-related pathologies. Identification of therapeutics that target senescent cells show promise for extending healthy aging. Here, we present a novel assay to screen for the identification of senotherapeutics based on measurement of senescence associated β-Galactosidase activity in single cells.

Video correlati

Read Article